After years of trying, Congress is finally on the verge of passing legislation aimed at lowering prescription drug prices by targeting the intermediaries that help negotiate them.

In an odd twist, two of the country’s leading pharmacy companies argued that anything they did wrong should have been obvious ...

Pharmacy benefit managers are facing more pressure after the Department of Labor issued new requirements for disclosing their ...

In a new lawsuit, Iowa Attorney General Brenna Bird alleges 18 companies have charged Iowans too much for insulin and ...

A policy meant to limit insurance profits under the Affordable Care Act is driving market consolidation and higher ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to ...

Penn State is suing a number of major insulin makers and other large health care companies, alleging they participated in an ...